Search
for
Sort by
Research 781–810 of 1000+
- 455 Beyond Immunity: TEC and JAK3 Kinase Activation in Melanocytes Drives Inflammation in Vitiligo
- Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- Clinical Trial Eligibility in Real‐World Alopecia Areata Patients Treated With Baricitinib
- Effectiveness and safety of baricitinib in severe alopecia areata: 48‐week results
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib
- A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database
- Acral Vitiligo: A Comprehensive Review of Clinical Features, Pathogenesis, and Novel Therapeutic Advances
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Exploring the Complexities of Atopic Dermatitis: Pathophysiological Mechanisms and Therapeutic Approaches
- A transcriptomic map of murine and human alopecia areata
- Primary cicatricial alopecias are characterized by dysregulation of shared gene expression pathways
- A phase 2a trial of brepocitinib for cicatricial alopecia
- RNA sequencing reveals lncRNA-mediated non-mendelian inheritance of feather growth change in chickens
- Comprehensive analysis of the expression profiles of mRNA, lncRNA, circRNA, and miRNA in primary hair follicles of coarse sheep fetal skin
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Identifying barriers and disparities in the healthcare of patients with alopecia areata: a mixed-methods analysis using claims data and qualitative interview data
- Combination Treatment with Methotrexate for Severe Alopecia Areata
- Vitiligo
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- Could baricitinib treat frontal fibrosing alopecia and facial papules?
- 62202 Network meta-analysis (NMA) of FDA-approved JAK inhibitors for alopecia areata (AA) with at least 50% hair loss per SALT score
- JAK inhibitors in dermatology: The promise of a new drug class
- JAK Inhibitors for Treatment of Alopecia Areata
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- 69 Risk-benefit appraisal of systemic JAK inhibitors for alopecia areata: a comprehensive meta-analysis assessing safety and adverse effects